<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title><![CDATA[RSS for Baxter International]]></title>
<description><![CDATA[Watch breaking news videos and read news updates about Baxter International on FOXBusiness.com.]]></description>
<link><![CDATA[http://www.foxbusiness.com/search-results/]]></link>
<atom:link xmlns:atom="http://www.w3.org/2005/Atom" type="application/rss+xml" rel="self" href="http://www.foxbusiness.com/search-results/urss?pageid=174596"/>
<item>
<title><![CDATA[Baxter's Potential Alzheimer's Treatment Immunoglobulin Misses Primary Endpoints]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/07/baxter-potential-alzheimer-treatment-immunoglobulin-misses-primary-endpoints/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/07/baxter-potential-alzheimer-treatment-immunoglobulin-misses-primary-endpoints/</guid>
<pubDate><![CDATA[Tue, 07 May 2013 08:19:34 EDT]]></pubDate>
<description><![CDATA[Baxter International Inc. (BAX) said results from a late-stage study of its potential treatment for Alzheimer's, immunoglobulin, were negative.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Health-Care Companies Report Slowdown in Patient Visits]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/23/health-care-companies-report-slowdown-in-patient-visits/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/23/health-care-companies-report-slowdown-in-patient-visits/</guid>
<pubDate><![CDATA[Tue, 23 Apr 2013 09:46:39 EDT]]></pubDate>
<description><![CDATA[The spike late last year in doctor and hospital visits apparently lasted as long as the flu.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Baxter's Sales Rise, But Health-Care Pressures Remain]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/18/baxter-sales-rise-but-health-care-pressures-remain/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/18/baxter-sales-rise-but-health-care-pressures-remain/</guid>
<pubDate><![CDATA[Thu, 18 Apr 2013 11:42:32 EDT]]></pubDate>
<description><![CDATA[Baxter International Inc. (BAX) reported a slight increase in first-quarter sales, as growth in emerging markets helped to offset continued pricing and utilization pressures in the U.S. and Europe, as well as new austerity measures in China.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Baxter 1st-Quarter Profit Off 11% on Acquisition-Related Charges]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/18/baxter-1st-quarter-profit-off-11-on-acquisition-related-charges/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/18/baxter-1st-quarter-profit-off-11-on-acquisition-related-charges/</guid>
<pubDate><![CDATA[Thu, 18 Apr 2013 07:35:13 EDT]]></pubDate>
<description><![CDATA[Baxter International Inc.'s (BAX) first-quarter earnings fell 11% as the medical-products company was hurt by acquisition-related charges and the year-earlier period included a tax benefit.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Market Wrap for Friday, March 22: Stocks Rise on Hopes of Bailout Deal for Cyprus]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/03/22/market-wrap-for-friday-march-22-stocks-rise-on-hopes-bailout-deal-for-cyprus/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/03/22/market-wrap-for-friday-march-22-stocks-rise-on-hopes-bailout-deal-for-cyprus/</guid>
<pubDate><![CDATA[Fri, 22 Mar 2013 12:17:11 EDT]]></pubDate>
<description><![CDATA[The U.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Gentium Gets Negative Opinion From CHMP; Biogen, Others Get Positive Opinions]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/03/22/gentium-gets-negative-opinion-from-chmp-biogen-others-get-positive-opinions/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/03/22/gentium-gets-negative-opinion-from-chmp-biogen-others-get-positive-opinions/</guid>
<pubDate><![CDATA[Fri, 22 Mar 2013 09:18:25 EDT]]></pubDate>
<description><![CDATA[Gentium SpA (GENT) said the European Medicines Agency's Committee for Medicinal Products for Human Use issued a negative opinion, recommending the refusal of marketing authorization for its treatment for hepatic veno-occlusive disease.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Insight - A casualty of the financial crisis: The corporate palace]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/03/04/insight-casualty-financial-crisis-corporate-palace/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/03/04/insight-casualty-financial-crisis-corporate-palace/</guid>
<pubDate><![CDATA[Mon, 04 Mar 2013 03:02:01 EST]]></pubDate>
<description><![CDATA[In the past year, defense company SAIC Inc has shrunk the office space it either owns or leases by 306,000 square feet (28,428 sq meters), the size of about five football fields.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[CSL Beats Expectations With 24% Increase in 1st Half Net Profit]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/02/12/csl-beats-expectations-with-24-increase-in-1st-half-net-profit/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/02/12/csl-beats-expectations-with-24-increase-in-1st-half-net-profit/</guid>
<pubDate><![CDATA[Tue, 12 Feb 2013 17:14:01 EST]]></pubDate>
<description><![CDATA[CSL Ltd. (CSL.AU), one of the world's biggest manufacturers of blood plasma and flu vaccines, said Wednesday its first half profit rose 24% as it capitalized on a rival's factory shutdown and reaped better-than-expected royalties from a key drug to prevent cervical cancer.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Cangene Wins Auction for Inspiration's Hemophilia Drug]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/02/06/cangene-wins-auction-for-inspiration-hemophilia-drug/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/02/06/cangene-wins-auction-for-inspiration-hemophilia-drug/</guid>
<pubDate><![CDATA[Wed, 06 Feb 2013 12:47:38 EST]]></pubDate>
<description><![CDATA[Inspiration Biopharmaceuticals Inc. reached a deal to sell its second development-stage hemophilia drug at auction Tuesday to Cangene Corp. for $5.9 million in cash upfront plus royalties and milestone payments worth $50 million.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Investor Raises Dividend as 4Q NAV/Share Rises 12% on Year]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/01/29/investor-raises-dividend-as-4q-navshare-rises-12-on-year/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/01/29/investor-raises-dividend-as-4q-navshare-rises-12-on-year/</guid>
<pubDate><![CDATA[Tue, 29 Jan 2013 03:02:58 EST]]></pubDate>
<description><![CDATA[Investor AB (INVE-B.SK), the Swedish investment company, Tuesday posted a 12% on-year rise in net asset value per share and raised its dividend, adding that it aims to return to its leverage target of 5%-10% following the closing of the Gambro transaction later this year.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Eurozone PMI Beats Expectations, Points Toward Contraction]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/2115715839001/eurozone-pmi-beats-expectations-points-toward-contraction/?]]></link>
<guid>http://video.foxbusiness.com/v/2115715839001/eurozone-pmi-beats-expectations-points-toward-contraction/</guid>
<pubDate><![CDATA[Thu, 24 Jan 2013 08:55:48 EST]]></pubDate>
<description><![CDATA[FBN’s Diane Macedo breaks down the stories moving the markets around the world.]]></description>
<media:thumbnail>http://a57.foxnews.com/media.foxbusiness.com/thumbnails/012413/640/360/011413_Imus_Macedo.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Baxter International 4th-Quarter Net Up 6.7%; Gives Downbeat 1st-Quarter View]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/01/24/baxter-international-4th-quarter-net-up-67-gives-downbeat-1st-quarter-view/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/01/24/baxter-international-4th-quarter-net-up-67-gives-downbeat-1st-quarter-view/</guid>
<pubDate><![CDATA[Thu, 24 Jan 2013 07:52:39 EST]]></pubDate>
<description><![CDATA[Baxter International Inc. (BAX) posted a 6.7% rise in fourth-quarter earnings as the company's focus on life-saving therapies continued to drive sales.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Medical Device Tax Driving Companies Out of U.S.?]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/2071219841001/medical-device-tax-driving-companies-out-of-us/?]]></link>
<guid>http://video.foxbusiness.com/v/2071219841001/medical-device-tax-driving-companies-out-of-us/</guid>
<pubDate><![CDATA[Thu, 03 Jan 2013 15:46:08 EST]]></pubDate>
<description><![CDATA[Cyberonics CEO Daniel Moore on the impact of the medical device tax on jobs and patient care.]]></description>
<media:thumbnail>http://a57.foxnews.com/media.foxbusiness.com/thumbnails/010313/640/360/010313_closing_moore.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Baxter's Investigational Hemophilia Treatment Yields Positive Results]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/12/10/baxter-investigational-hemophilia-treatment-yields-positive-results/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/12/10/baxter-investigational-hemophilia-treatment-yields-positive-results/</guid>
<pubDate><![CDATA[Mon, 10 Dec 2012 09:33:40 EST]]></pubDate>
<description><![CDATA[Baxter International Inc. (BAX) said results from a study evaluating its investigational treatment for patients with hemophilia B were positive.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Baxter to buy Sweden's Gambro for $4 billion]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/12/04/baxter-to-buy-sweden-gambro-for-4-billion/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/12/04/baxter-to-buy-sweden-gambro-for-4-billion/</guid>
<pubDate><![CDATA[Tue, 04 Dec 2012 12:52:08 EST]]></pubDate>
<description><![CDATA[Healthcare products maker Baxter International Inc said on Tuesday that it would buy privately held Swedish dialysis product company Gambro AB for about $4 billion to expand its kidney therapy portfolio.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[MARKET SNAPSHOT: U.S. Stocks Retreat With Fiscal Cliff In View]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/12/04/market-snapshot-us-stocks-retreat-with-fiscal-cliff-in-view/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/12/04/market-snapshot-us-stocks-retreat-with-fiscal-cliff-in-view/</guid>
<pubDate><![CDATA[Tue, 04 Dec 2012 12:25:57 EST]]></pubDate>
<description><![CDATA[U.S. stock indexes fell modestly Tuesday as U.S. political leaders readied for more budgets talks to avert steep tax hikes and spending cuts that could push the economy into recession.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Baxter International Buys Gambro for $4B]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/2010717321001/baxter-international-buys-gambro-for-4b/?]]></link>
<guid>http://video.foxbusiness.com/v/2010717321001/baxter-international-buys-gambro-for-4b/</guid>
<pubDate><![CDATA[Tue, 04 Dec 2012 12:19:28 EST]]></pubDate>
<description><![CDATA[FOX Business brief: Late-morning markets]]></description>
<media:thumbnail>http://a57.foxnews.com/media.foxbusiness.com/thumbnails/120412/640/360/120412_fb_brief11.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[UPDATE 2-Baxter to buy Sweden's Gambro for about $4 billion]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/12/04/update-2-baxter-to-buy-sweden-gambro-for-about-4-billion724334/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/12/04/update-2-baxter-to-buy-sweden-gambro-for-about-4-billion724334/</guid>
<pubDate><![CDATA[Tue, 04 Dec 2012 11:45:37 EST]]></pubDate>
<description><![CDATA[Baxter International Inc said on Tuesday that it would buy privately held Swedish dialysis product company Gambro AB for about $4 billion to complement its kidney therapy portfolio.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[MARKET SNAPSHOT: U.S. Stock Indexes Stable On Fiscal-cliff View]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/12/04/market-snapshot-us-stock-indexes-stable-on-fiscal-cliff-view/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/12/04/market-snapshot-us-stock-indexes-stable-on-fiscal-cliff-view/</guid>
<pubDate><![CDATA[Tue, 04 Dec 2012 11:16:00 EST]]></pubDate>
<description><![CDATA[U.S. stock indexes were little changed Tuesday as U.S. political leaders readied for more budgets talks to avert steep tax hikes and spending cuts that could push the economy into recession.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Baxter to buy Sweden's Gambol for about $4 billion]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/12/04/baxter-to-buy-sweden-gambol-for-about-4-billion/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/12/04/baxter-to-buy-sweden-gambol-for-about-4-billion/</guid>
<pubDate><![CDATA[Tue, 04 Dec 2012 10:30:06 EST]]></pubDate>
<description><![CDATA[Baxter International Inc said on Tuesday that it would buy privately held Swedish dialysis product company Gambro AB for about $4 billion to complement its kidney therapy portfolio.]]></description>
<media:thumbnail/>
</item>
</channel>
</rss>
